Survey Finds Researchers Most Likely to Purchase Ion Torrent PGM, MiSeq, HiSeq over Next Year | GenomeWeb

A survey conducted by GenomeWeb in partnership with investment firm Mizuho Securities indicates that researchers looking to purchase a next-gen sequencer over the next 12 months are most likely to purchase Life Technologies' Ion Torrent PGM and Illumina's HiSeq and MiSeq instruments.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.